Found: 8
Select item for more details and to access through your institution.
MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.
- Published in:
- SCIENCE CHINA Life Sciences, 2020, v. 63, n. 9, p. 1, doi. 10.1007/s11427-019-1627-y
- By:
- Publication type:
- Article
Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01913-5
- By:
- Publication type:
- Article
Ranolazine prevents pressure overload‐induced cardiac hypertrophy and heart failure by restoring aberrant Na<sup>+</sup> and Ca<sup>2+</sup> handling.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 7, p. 11587, doi. 10.1002/jcp.27791
- By:
- Publication type:
- Article
Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.707399
- By:
- Publication type:
- Article
Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 13, p. 2805, doi. 10.1093/cvr/cvab325
- By:
- Publication type:
- Article
role of CD36 in cardiovascular disease.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 1, p. 115, doi. 10.1093/cvr/cvaa319
- By:
- Publication type:
- Article
Erratum to: MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS).
- Published in:
- Cancer Communications, 2022, v. 42, n. 5, p. 476, doi. 10.1002/cac2.12260
- By:
- Publication type:
- Article